Readmissions are being increasingly used as an indicator of quality of care.
Dr Kaci Christian and colleagues identified risk factors for 30-day readmission in hospitalized patients with inflammatory bowel disease.
Patients with inflammatory bowel disease hospitalized between 2004 and 2013 at the University of Maryland were identified.
Demographic and clinical information were extracted from the medical record for each admission.
Multivariate logistic regression was performed to determine the association between these variables and readmission.
The research team identified 1213 admissions in 498 patients.
|Underweight or obese patients were nearly twice as likely to be readmitted|
|Inflammatory Bowel Diseases|
The team followed 19% of index admissions by a 30-day readmission.
Approximately 70% of the population was white, 60% were women, and 68% had Crohn's disease.
Concurrent congestive heart failure and chronic obstructive pulmonary disease, history of steroid use, diverting ileostomy, subtotal colectomy, or a thromboembolic event during index admission, and IV antibiotics or restricted diet at discharge were associated with readmission.
The researchers noted that patients with congestive heart failure or chronic obstructive pulmonary disease were more likely to be readmitted.
Underweight or obese patients were nearly twice as likely to be readmitted.
The research team found that those with past steroid use, new ileostomy, or those who were discharged on hyperalimentation were twice as likely to be readmitted.
Dr Christian's team concludes, "Nineteen percentage of patients with inflammatory bowel disease treated at a referral center are readmitted within 30 days."
"Our results suggest that patients with comorbid medical conditions, malnutrition or obesity, a new ileostomy, past steroid use, or those discharged on hyperalimentation are at increased risk for readmission."
"Research is needed to determine if targeted interventions for high-risk patients decreases readmissions."